Goldline Pharmaceutical Ltd Quarterly Result
Goldline Pharmaceutical Ltd
NSE: GLPL
Net Profit - Last Quarter
Goldline Pharmaceutical Ltd Quarterly Results Key Highlights
- The revenue of Goldline Pharmaceutical Ltd for the Mar '26 is ₹ 9.79 crore as compare to the Dec '25 revenue of ₹ 7.52 crore.
- This represent the growth of 30.19% The ebitda of Goldline Pharmaceutical Ltd for the Mar '26 is ₹ 2.78 crore as compare to the Dec '25 ebitda of ₹ 1.52 crore.
- This represent the growth of 82.89% The net profit of Goldline Pharmaceutical Ltd for the Mar '26 is ₹ 1.89 crore as compare to the Dec '25 net profit of ₹ 0.87 crore.
- This represent the growth of 117.24%.
Goldline Pharmaceutical Ltd Quarterly Results Analysis
Market Price of Goldline Pharmaceutical Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 28 Jul 2026 | 37.66 |
| 27 Jul 2026 | 38.37 |
| 24 Jul 2026 | 38.13 |
| 22 Jul 2026 | 39.99 |
| 21 Jul 2026 | 41 |
| 20 Jul 2026 | 40.09 |
| 17 Jul 2026 | 40.49 |
| 16 Jul 2026 | 39.05 |
| 15 Jul 2026 | 39.02 |
| 14 Jul 2026 | 38.84 |
Historical Revenue of Goldline Pharmaceutical Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Goldline Pharmaceutical Ltd
Historical EBITDA of Goldline Pharmaceutical Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Goldline Pharmaceutical Ltd
Historical Net Profit of Goldline Pharmaceutical Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Goldline Pharmaceutical Ltd
Goldline Pharmaceutical Ltd News Hub
BSE SME Goldline Pharmaceutical delivers a dose of listing gains
The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stoc
Read more
19 May 26
Goldline Pharmaceutical to discuss results
Goldline Pharmaceutical will hold a meeting of the Board of Directors of the Company on 9 June 2026.
Read more
03 Jun 26
Popular Search
About Goldline Pharmaceutical Ltd
- Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai.
- Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f.
- September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.
- Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente.
- The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company.
